140 related articles for article (PubMed ID: 11405652)
21. Anticonvulsant action in the epileptic gerbil of novel inhibitors of GABA uptake.
Löscher W
Eur J Pharmacol; 1985 Mar; 110(1):103-8. PubMed ID: 4007046
[TBL] [Abstract][Full Text] [Related]
22. GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representative.
N'Goka V; Schlewer G; Linget JM; Chambon JP; Wermuth CG
J Med Chem; 1991 Aug; 34(8):2547-57. PubMed ID: 1831508
[TBL] [Abstract][Full Text] [Related]
23. Kinetic characterization of inhibition of gamma-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3-butenyl derivatives of nipecotic acid and guvacine.
Larsson OM; Falch E; Krogsgaard-Larsen P; Schousboe A
J Neurochem; 1988 Mar; 50(3):818-23. PubMed ID: 3339356
[TBL] [Abstract][Full Text] [Related]
24. Anticonvulsant activity of the glial GABA uptake inhibitor, THAO, in chemical seizures.
Gonsalves SF; Twitchell B; Harbaugh RE; Krogsgaard-Larsen P; Schousboe A
Eur J Pharmacol; 1989 Sep; 168(2):265-8. PubMed ID: 2532604
[TBL] [Abstract][Full Text] [Related]
25. (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier.
Braestrup C; Nielsen EB; Sonnewald U; Knutsen LJ; Andersen KE; Jansen JA; Frederiksen K; Andersen PH; Mortensen A; Suzdak PD
J Neurochem; 1990 Feb; 54(2):639-47. PubMed ID: 2299358
[TBL] [Abstract][Full Text] [Related]
26. Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain.
Bonanno G; Raiteri M
Br J Pharmacol; 1987 May; 91(1):237-43. PubMed ID: 3594080
[TBL] [Abstract][Full Text] [Related]
27. beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.
Stevenson A; Wingrove PB; Whiting PJ; Wafford KA
Mol Pharmacol; 1995 Dec; 48(6):965-9. PubMed ID: 8848011
[TBL] [Abstract][Full Text] [Related]
28. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C
Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497
[TBL] [Abstract][Full Text] [Related]
29. Phosphorus analogues of gamma-aminobutyric acid, a new class of anticonvulsants.
Cates LA; Li VS; Yakshe CC; Fadeyi MO; Andree TH; Karbon EW; Enna SJ
J Med Chem; 1984 May; 27(5):654-9. PubMed ID: 6325692
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I).
Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H
Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibitors of glial GABA uptake: synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues.
Falch E; Perregaard J; FrŁlund B; SŁkilde B; Buur A; Hansen LM; Frydenvang K; Brehm L; Bolvig T; Larsson OM; Sanchez C; White HS; Schousboe A; Krogsgaard-Larsen P
J Med Chem; 1999 Dec; 42(26):5402-14. PubMed ID: 10639282
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of the GABA uptake systems.
Krogsgaard-Larsen P
Mol Cell Biochem; 1980 Jun; 31(2):105-21. PubMed ID: 6251361
[TBL] [Abstract][Full Text] [Related]
33. In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine.
Suzdak PD; Swedberg MD; Andersen KE; Knutsen LJ; Braestrup C
Life Sci; 1992; 51(24):1857-68. PubMed ID: 1333027
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
Quandt G; Höfner G; Wanner KT
Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
[TBL] [Abstract][Full Text] [Related]
35. Effect of homo-beta-proline and other heterocyclic GABA analogues on GABA uptake in neurons and astroglial cells and on GABA receptor binding.
Larsson OM; Thorbek P; Krogsgaard-Larsen P; Schousboe A
J Neurochem; 1981 Dec; 37(6):1509-16. PubMed ID: 6278078
[TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels.
Kombian SB; Edafiogho IO; Ananthalakshmi KV
Br J Pharmacol; 2005 Aug; 145(7):945-53. PubMed ID: 15912138
[TBL] [Abstract][Full Text] [Related]
37. Effects of γ-Aminobutyric acid transporter 1 inhibition by tiagabine on brain glutamate and γ-Aminobutyric acid metabolism in the anesthetized rat In vivo.
Patel AB; de Graaf RA; Rothman DL; Behar KL
J Neurosci Res; 2015 Jul; 93(7):1101-8. PubMed ID: 25663257
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of the GABA uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the rat ventrolateral thalamus.
Richards DA; Bowery NG
Neurochem Res; 1996 Feb; 21(2):135-40. PubMed ID: 9182238
[TBL] [Abstract][Full Text] [Related]
39. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
Benes J; Parada A; Figueiredo AA; Alves PC; Freitas AP; Learmonth DA; Cunha RA; Garrett J; Soares-da-Silva P
J Med Chem; 1999 Jul; 42(14):2582-7. PubMed ID: 10411478
[TBL] [Abstract][Full Text] [Related]
40. Amplification by glycine of the anticonvulsant effect of THPO, a GABA uptake inhibitor.
Seiler N; Sarhan S; Krogsgaard-Larsen P; Hjeds H; Schousboe A
Gen Pharmacol; 1985; 16(5):509-11. PubMed ID: 2932364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
